Tech Company Financing Transactions
Intervention Insights Funding Round
Intervention Insights, operating out of Waltham, secured $7.2 million from Beringea, Chrysalis Ventures and Hopen Life Science Ventures.
Transaction Overview
Company Name
Announced On
7/18/2011
Transaction Type
Venture Equity
Amount
$7,200,000
Round
Series B
Investors
Beringea (Lead Investor) (Michael Gross)
Chrysalis Ventures (Lead Investor) (Koleman Karleski)
Proceeds Purpose
The investment will enable the company to expand the commercialization of its OncInsights product platform, while furthering strategic relationships in the cancer care industry.
Company Information
Company Status
Private & Independent
Industry
Enterprise IT
Mailing Address
1601 Trapelo Rd. 178
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Our technology-enabled service helps physicians make evidence-based decisions using the latest science in molecular oncology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Ephraim Hochberg
Chief Executive Officer
Clynt Taylor
Chief Marketing Officer
Karan Cushman
Vice President
Jerome Madison
VP - Product Management
Russell Ingersoll
Browse more venture capital transactions:
Prev: 7/18/2011: Digicert venture capital transaction
Next: 7/18/2011: MoboTap venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs